3,459
Views
7
CrossRef citations to date
0
Altmetric
Editorials

Making sense of pharmaceutical cognitive enhancement: taking stock and looking forward

&

References

  • Bailey, L., Griffin, C., & Shankar, A. (2015). ‘Not a good look’: Impossible dilemmas for young women negotiating the culture of intoxication in the United Kingdom. Substance Use and Misuse, 50, 747–758. doi:10.3109/10826084.2015.978643
  • Beyer, C., Staunton, C., & Moodley, K. (2014). The implications of methylphenidate use by healthy medical students and doctors in South Africa. BMC Medical Ethics, 15, 20. doi:10.1186/1472-6939-15-20
  • Bjønness, J. (2018). Et udstrakt selv: Unges brug af medicinsk kognitiv forbedring for at trives og præstere bedre under uddannelse. Tidsskrift for Forskning i Sygdom og Samfund, 15, 87–111. doi:10.7146/tfss.v15i28.107261
  • Bjønness, J. (2019). Gendered aspects of Danish students’ non-medical use of prescription pharmaceuticals for enhancement purposes in the ‘performance society’. Drugs: Education, Prevention and Policy, 26, 309–318. doi:10.1080/09687637.2019.1590530.
  • Blum, L.M., & Stracuzzi, N.F. (2004). Gender in the prosaz nation. Popular discourse and productive femininity. Gender & Society, 18, 269–286. doi:10.1177/0891243204263108
  • Campbell, N. (2000). Using Women: Gender, drug policy and social justice. New York: Routledge.
  • Chatterjee, A. (2004). Cosmetic neurology. The controversy over enhancing movement, mentation and mood. Neutrology, 63, 968–974.
  • Christensen, A.-D., & Jensen, S.Q. (2012). Doing intersectional analysis. Methodological implications for qualitative research. Nora- Nordic Journal for Feminist and Gender Research, 20, 109–125. doi:10.1080/08038740.2012.673505
  • Cloatre, E., & Pickersgill, M. (2014). International law, public health, and the meanings of pharmaceuticalization. New Genet Soc, 33, 434–449. doi:10.1080/14636778.2014.951994
  • Connell, R. (1995). Masculinities. Cambridge: Polity Press.
  • Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore, MD: JHU Press.
  • Coveney, C. M. (2010). Awakening expectations: Exploring social and ethical issues surrounding the medical and non-medical uses of cognition enhancing drugs in the UK (Doctoral dissertation, University of Nottingham).
  • Coveney, C. (2011). Cognitive enhancement? Exploring modafinil use in social context. Sociological Reflections on the Neurosciences. Advances in Medical Sociology. Advance online publication. doi:10.1080/09687637.2019.1593318
  • Coveney, C.M. (2014). Managing sleep and wakefulness in a 24 hour world. Sociology of Health and Illness, 36, 123–136. doi:10.1111/1467-9566.12046
  • Coveney, C., Gabe, J., & Williams, S. (2011). The sociology of cognitive enhancement: Medicalisation and beyond. Health Sociology Review, 20, 381–393. doi:10.5172/hesr.2011.372
  • Coveney, C.M., Nerlich, B., & Martin, P. (2009). Modafinil in the media: Metaphors, medicalisation and the body. Social Science and Medicine, 68, 487–495. doi:10.1016/j.socscimed.2008.11.016
  • Coveney, C., Williams, S., & Gabe, J. (2019). Enhancement imaginaries: Exploring public understandings of pharmaceutical cognitive enhancing drugs. Drugs: Education, Prevention and Policy, 26, 319–328. doi:10.1080/09687637.2019.1593318.
  • Crenshaw, K.W. (1989). Demarginalizing the intersection of race and sex: A black feminist critique of antidiscrimination doctrine, feminist theory and anti-racist politics. Chicago, IL: University of Chicago Legal Forum. University of Chicago.
  • Danish Council of Ethics. (2011). Medical enhancement, English summary. 1–12. København. Rosendahls: Det etiske Råd.
  • Dees, R. (2008). Better brains, better selves? The ethics of neuroenhancement. Kennedy Institute of Ethics Journal, 17, 371–395. doi:10.1353/ken.2008.0001
  • DeSantis, A.D., & Hane, A.C. (2010). Adderal is definitely not a drug: justifications for the illegal use of ADHD stimulants. Substance Use and Misuse, 45, 31–46. doi:10.3109/10826080902858334
  • Dresler, M., Sandberg, A., Bublitz, C., Ohla, K., Trenado, C., Mroczko-Wąsowicz, A., … Repantis, D. (2019). Hacking the brain: Dimensions of cognitive enhancement. ACS Chemical Neuroscience, 10, 1137–1148. doi:10.1021/acschemneuro.8b00571
  • Ettorré, E. (2007). Revisioning women and drug use. Gender, power and the body. Basingstoke: Palgrave. Macmillan.
  • Farah, M.J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., … Wolpe, P.R. (2004). Neurocognitive enhancement: What can we do and what should we do? Nature Reviews Neuroscience, 5, 421–425. doi:10.1038/nrn1390
  • Farah, M.J., Smith, M.E., Ilieva, I., & Hamilton, R.H. (2014). Cognitive enhancement. Wiley Interdisciplinary Reviews: Cognitive Science, 5, 95–103. doi:10.1002/wcs.1250
  • Forlini, C., & Racine, E. (2011). Considering the causes and implications of ambivalence in using medicine for enhancement. American Journal of Bioethics, 11, 15–17. doi:10.1080/15265161.2011.534952
  • Forlini, C., & Racine, E. (2009). Disagreement with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics, 10, 1–13. doi:10.1186/1472-6939-10-9
  • Gabe, J., Coveney, C.M., & Williams, S.J. (2016). Prescriptions and proscriptions: Moralising sleep medicines. Sociology of Health and Illness, 38, 627–644. doi:10.1111/1467-9566.12383
  • Gabe, J., & Lipshitz-Phillips, S. (1982). Evil necessity? The meaning of benzodiazepine use for women patients from one general practice. Sociology of Health & Illness, 4, 201–209. doi:10.1111/1467-9566.ep11339945
  • Gabe, J., & Lipshitz-Phillips, S. (1984). Tranquillisers as social control? Sociological Review, 32, 524–546. doi:10.1111/j.1467-954X.1984.tb00825.x
  • Gabe, J., & Thorogood, N. (1986). Prescribed drug use and the management of everyday life: The experiences of black and white working class women. Sociological Review, 34, 737–772. doi:10.1111/j.1467-954X.1986.tb00695.x
  • Gabe, J., Williams, S., Martin, P., & Coveney, C. (2015). Pharmaceuticals and society: Power, promises and prospects. Social Science & Medicine, 131, 193–198. doi:10.1016/j.socscimed.2015.02.031
  • Greely, H., Sahakian, B., Harris, J., Kessler, R.C., Gazzaniga, M., Campbell, P. & Farah, M.J. (2008). Towards responsible use of cognitive-enhancing drugs by the health. Nature, 456, 702–705. doi:10.1038/456702a
  • Heyes, A. (2019). Psychosocial factors facilitating use of cognitive enhancing drugs in education: A qualitative investigation of moral disengagement and associated processes. Drugs: Education, Prevention and Policy, 26, 329–338. doi:10.1080/09687637.2019.1586831.
  • Hildt, E., Lieb, K., & Francke, A.G. (2014). Life context of pharmacological academic performance enhancement among university students – a qualitative approach. BMC Med Ethics, 15, 23. doi:10.1186/1472-6939-15-23
  • Hunt, G., & Antin, T. (2019). Gender and intoxication: From masculinity to intersectionality. Drugs: Education, Prevention and Policy, 26, 70–78. doi:10.1080/09687637.2017.1349733
  • Hunt, G., & Barker, J. (2001). Socio-cultural anthropology and alcohol and drug research:towards a unified theory. Social Science & Medicine, 53, 165–188. doi:10.1016/S0277-9536(00)00329-4
  • Hyman, S.E. (2011). Cognitive enhancement: promises and perils. Neuron, 69, 595–598. doi:10.1016/j.neuron.2011.02.012
  • Jensen, C., Forlini, C., Partridge, B., & Hall, W. (2016). Australian university students’ coping strategies and use of pharmaceutical stimulants as cognitive enhancers. Frontiers in psychology, 7, 277.
  • King, D. (2005). Drugs futures 2025, UK Government Office for Science and Technology, Report Published 13th July 2005. Accessible at: https://www.gov.uk/government/publications/drugs-futures-2025
  • Krøll, L. (2019). Students’ non-medical use of pharmaceuticals to manage time in everyday life crises. Drugs: Education, Prevention and Policy, 26, 339–346. doi:10.1080/09687637.2019.1585760.
  • LeClair, A., Kelly, B.C., Pawson, M., Wells, B.E., & Parsons, J.T. (2015). Motivations for prescription drug misuse among young adults: Considering social and developmental contexts. Drugs: Education, Prevention and Policy, 22, 208–216. doi:10.3109/09687637.2015.1030355
  • Loe, M., & Cuttino, L. (2008). Grappling with the medicated self: The case of ADHD college students. Symbolic Interaction, 31, 304–322.
  • Lopes, N., Clamote, T., Raposo, H., Pegado, E., & Rodrigues, C. (2015). Medications, youth therapeutic cultures and performance consumptions: A sociological approach. Health, 19, 430–448. doi:10.1177/1363459314554317
  • Lucke, J., Jensen, C., Dunn, M., Chan, G., Forlini, C., Kaye, S., … Hall, W. (2018). Non-medical prescription stimulant use to improve academic performance among Australian university students: Prevalence and correlates of use. BMC Public Health, 18, 1270. doi:10.1186/s12889-018-6212-0
  • Maier, L.J., Ferris, J.A., & Winstock, A.R. (2018). Pharmacological cognitive enhancement among non-ADHD – A cross-sectional study in 15 countries. International Journal of Drug Policy, (58), 104–112. doi:10.1016/j.drugpo.2018.05.009
  • Mamo, L., & Fishman, J.R. (2001). Potency in all the right places: Viagra as a technology of the gendered body. Body & Society, 7, 13–35. doi:10.1177/1357034X01007004002
  • Maslen, H., Faulmüller, N., & Savulescu, J. (2014). Pharmacological cognitive nenhancement – hoe neuroscientific research could advance ethical debate. Neuroscience, 8, 1–12.
  • Mazanov, J., Dunn, M., Connor, J., & Fielding, M.L. (2013). Substance use to enhance academic performance among Australian university students. Performance Enhancement & Health, 2, 110–118. doi:10.1016/j.peh.2013.08.017
  • McCabe, S.E., West, B.T., Teter, J.C., & Boyd, C. (2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviours, 39, 1176–1182. doi:10.1016/j.addbeh.2014.03.008
  • Measham, F. (2002). ‘Doing gender – doing drugs’: Conceptualizing the gendering of drug cultures. Contemporary Drug Problems, 29, 335–373. doi:10.1177/009145090202900206
  • Miller, J. (2001). One of the guys. girls, gangs and gender. New York: Oxford University Press.
  • Miller, J., & Carbone-Lopez, K. (2015). Beyond ‘doing gender’: Incorporating race, class, place, and life transitions into feminist drug research. Subst Use Misuse, 50, 693–707. doi:10.3109/10826084.2015.978646
  • Nagel, S.K. (2010). Too much of a good thing? Enhancement and the burden of self-determination. Neuroehics, 3, 109–119. doi:10.1007/s12152-010-9072-6
  • North, D., Davis, P., & Powell, A. (1995). Patient responses to benzodiazepine medicine: A typology of adaptive repertoires developed by long term users. Sociology of Health & Illness, 17, 632–650. doi:10.1111/1467-9566.ep10932138
  • Nuffield Council on Bioethics (2019). What’s on the horizon for bioethics? Report published online January 2019. Accessible at: http://nuffieldbioethics.org/wp-content/uploads/The-bioethics-horizon.pdf
  • Ortega, F., Barros, D., Caliman, L., Itaborahy, C., Junqueira, L., & Ferreira, C.P. (2010). Ritalin in Brazil: Production, discourse and practices. Interface (Botucatu), 14, 499–512. doi:10.1590/S1414-32832010005000003
  • Oudshoorn, N. (1999). On masculinities, technologies, and pain: The testing of male contraceptives in the clinic and the media. Science, Technology, & Human Values, 24, 265–289. doi:10.1177/016224399902400204
  • Oudshoorn, N., Saetnan, A.R., & Lie, M. (2002, July). On gender and things: Reflections on an exhibition on gendered artifacts. In Women’s Studies International Forum 25 (4), 471-483). Pergamon. doi:10.1016/S0277-5395(02)00284-4
  • Parens, E. (1998). Enhancing human traits: Ethical and social implications (pp. 29–47). Wahington, DC: Georgetown Univeristy Press.
  • Partridge, B., Bell, S., Lucke, J., & Hall, W. (2013). Australian university students’ attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety. Drug and Alcohol Review, 32, 295–302. doi:10.1111/dar.12005
  • Partridge, B.J., Bell, S.K., Lucke, J.C., Yeates, S., & Hall, W.D. (2011). Smart drugs “as common as coffee: media hype about neuroenhancement”. PLoS One, 6, e28416. doi:10.1371/journal.pone.0028416
  • Petersen, M.A., Nørgaard, L.S., & Traulsen, J.M. (2015). Going to the doctor with enhancement in mind – an ethnographic study of university students’ use of prescription stimulants and their moral ambivalence. Drugs: Educcation Prevention and Policy, 22, 201–207. doi:10.3109/09687637.2014.970517
  • Petersen, M.A., & Petersen, T.S. (2019). Why prohibit study drugs? On attitudes and practices concerning prohibition and coercion to use pharmaceutical cognitive enhancement. Drugs: Education, Prevention and Policy, 26, 356–364, doi:10.1080/09687637.2019.1573878
  • Petersen, A., & Willig, R. (2004). Work and recognition reviewing new forms of pathological developments. Acta Sociologica, 47, 338–350. doi:10.1177/0001699304048667
  • Pickersgill, M., & Hogle, L. (2015). Enhancement, ethics and society: towards an empirical research agenda for the medical humanities and social sciences. Medical Humanities, 41, 136–142. doi:10.1136/medhum-2015-010718
  • Polak, L. (2017). What is wrong with ‘being a pill-taker’? The special case of statins. Sociol Health Illn, 39, 599–613. doi:10.1111/1467-9566.12509
  • Potts, A., Gavey, N., Grace, V.M., & Vares, T. (2003). The downside of Viagra: women’s experiences and concerns. Sociol Health Illn, 25, 697–719. doi:10.1046/j.1467-9566.2003.00366.x
  • Pyke, K.D., & Johnson, D.L. (2003). Asian American women and racialized femininities. ‘Doing’ gender cross cultural worlds. Gender & Society, 17, 33–53. doi:10.1177/0891243202238977
  • Racine, E., & Forlini, C. (2010). Cognitive enhancement, lifestyle choice or misuse of prescription drugs? Neuroethics, 3, 1–4. doi:10.1007/s12152-008-9023-7
  • Ram, S., Hussainy, S., Henning, M., Jensen, M., & Russell, B. (2016). Prevalence of cognitive enhancer use among New Zealand tertiary students. Drug and Alcohol Review, 35, 345–351. doi:10.1111/dar.12294
  • Reubi, D. (2013). Re-moralising medicine: The bioethical thought collective and the regulation of the body in British medical research. Social Theory & Health, 11, 215–235. doi:10.1057/sth.2012.15
  • Rose, N. (2007). Beyond medicalisation. Lancet, 369, 700–702. doi:10.1016/S0140-6736(07)60319-5
  • Sahakian, B.J., & Morein-Zamir, S. (2011). Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology, 25, 197–204. doi:10.1177/0269881109106926
  • Sales, P., Murphy, F., Murphy, S., & Lau, N. (2019). Burning the candle at both ends: motivations for non-medical prescription stimulant use in the American workplace. Drugs: Education, Prevention and Policy, 26, 301–308. doi:10.1080/09687637.2019.1606895.
  • Sattler, S. (2019). Nonmedical use of prescription drugs for cognitive enhancement as response to chronic stress especially when social support is lacking. Stress and Health, 35, 127–137. doi:10.1002/smi.2846
  • Schelle, K.J., Olthof, B.M.J., Reintjes, W., Bundt, C., Gusman-Vermeer, J., & van Mil, A.C.C.M. (2015). A survey of substance use for cognitive enhancement by university students in the Netherlands. Front Syst Neurosci. 9:10. doi:10.3389/fnsys.2015.00010
  • Shoemaker, P.J., & Reese, S.D. (2013). Mediating the message in the 21st century: A media sociology perspective. London. Routledge.
  • Singh, I., Bard, I., & Jackson, J. (2014). Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One, 9, e105969. doi:10.1371/journal.pone.0105969
  • Sørensen, N.U., Pless, M., Katznelson, N., & Nielsen, M.L. (2017). Picture Perfect. Praestationsoreinteringer blandt unge i forskellie ungdomslivskontekster. Tidsskrift for Ungdomsforskning, 17, 27–48.
  • Steward, A., & Pickersgill, M. (2019). Developing expertise, customising sleep, enhancing study practices: exploring the legitimisation of modafinil use within the accounts of UK undergraduate students. Drugs: Education, Prevention and Policy, 26, 347–355. doi:10.1080/09687637.2018.1555231.
  • Varga, M.D. (2012). Adderall abuse on college campuses: a comprehensive literature review. Journal of Evidence-Based Social Work, 9, 293–313. doi:10.1080/15433714.2010.525402
  • Venn, S., & Arber, S. (2012). Understanding older peoples’ decisions about the use of sleeping medication: issues of control and autonomy. Sociol Health Illn, 34, 1215–1229. doi:10.1111/j.1467-9566.2012.01468.x
  • Vrecko, S. (2013). Just how Cognitive is “cognitive enhancement”? On the significance of emotions in university students’ experiences with study drugs. AJOB Neuroscience, 4, 4–12. doi:10.1080/21507740.2012.740141
  • West, C., & Zimmerman, D.H. (1987). Doing gender. Gender and Society, 1, 125–151. doi:10.1177/0891243287001002002
  • Williams, S.J., Coveney, C.M., & Gabe, J. (2013). Medicalisation or customisation? Sleep, enterprise and enhancement in the 24/7 society. Social Science and Medicine, 79, 40–47. doi:10.1016/j.socscimed.2012.07.017
  • Williams, S.J., Higgs, P., & Katz, S. (2012). Neuroculture, active ageing and the ‘older brain’: Problems, promises and prospects. Sociology of Health & Illness, 34, 64–78. doi:10.1111/j.1467-9566.2011.01364.x
  • Williams, S.J., Katz, S., & Martin, P. (2011). Neuroscience and medicalisation: Sociological reflections on memory, medicine and the brain. In M.D. Pickersgill & I. van Kaulen (Eds.). Sociological reflections on the neurosciences (pp. 231–254). Bradford: Emerald Group Publishing Limited.
  • Williams, S.J., Seale, C., Boden, S., Lowe, P., & Steinberg, D.L. (2008). Waking up to sleepiness: Modafinil, the media and the pharmaceuticalisation of everyday/night life. Sociology of Health and Illness, 30, 839–855. doi:10.1111/j.1467-9566.2008.01084.x
  • Willig, R. (2005). Selvrealiseringsoptioner – vor tids fordring om anerkendelse. In R. Willig & M. Østergaard (Ed.), Sociale patologier. København: Hans Retitzel.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.